Article Sidebar

Published: 2022-01-06
Abstract Views: 360
DOI: https://doi.org/10.52163/yhc.v63i1.261
Issue
Vol. 63 No. 1 (2022)
Section
Articles
How to Cite
Hậu, H. T. K. ., Tiên, P. T. T. ., Nghiệp, T. T. ., & Hiếu, N. P. T. . (2022). EFFICACY AND SAFETY OF MICROPULSE TRANSSCLERAL DIODE LASER CYCLOPHOTOCOAGULATION IN ABSOLUTE GLAUCOMA. Vietnam Journal of Community Medicine, 63(1). https://doi.org/10.52163/yhc.v63i1.261

EFFICACY AND SAFETY OF MICROPULSE TRANSSCLERAL DIODE LASER CYCLOPHOTOCOAGULATION IN ABSOLUTE GLAUCOMA

Hoang Thi Kieu Hau1, Pham Thi Thuy Tien2, Nghiệp Nghiep2, Nguyen Pham Trung Hieu3
1 General Hospital of Binh Duong Province
2 Eye Hospital HCMC
3 Medical and Pharmaceutical University of HCMC

Main Article Content

Abstract

Purposess: To evaluate the effectiveness of lowering intraocular pressure and the safety of Micropulse Transscleral diode laser cyclophotocoagulation (MP-TSCPC) with a duty cycle of 31,3% in absolute glaucoma patients.


Methods: A prospective interventional study was performed on 64 eyes from October 2020 to April 2021 at the Ho Chi Minh City Eye Hospital.


Results: Sixty four patients including 26 females and 38 males were recruited with the mean age 56.1±2.1. The mean IOP at pre- and post-opereration was 45.9±11.0 and 25.8±13.8mmHg, respectively. The average IOP reduced 42.4%, 33.5%, 39.1% and 45.5% from baseline after surgery at 1 week, 1 month, 3 months and 6 months (p value <0,001). 93,7% of patients improved pain symptoms after MP-TSCPC. The mean number of antiglaucoma medication was down from 3.5 ± 0.69 at the begining to 1.6 ± 0.78 at the end of the study. No serious complications were recorded.


Conclusion: Micropulse Transscleral diode laser cyclophotocoagulation with a duty cycle of 31,3% is an effective and safe method to lower intraocular pressure and relieve pain in absolute glaucoma.

Article Details

Keywords

Glaucoma, Micropulse transcleral cyclophotocoagulation.

References

1. Aquino MC, Barton K, Tan AM et al., "Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study". Clin Exp Ophthalmol, 2015, 43 (1), 40-6.
2. Benhatchi N, Bensmail D, Lachkar Y, "Benefits of SubCyclo Laser Therapy Guided by High-frequency Ultrasound Biomicroscopy in Patients With Refractory Glaucoma". J Glaucoma, 2019, 28 (6), 535-539.
3. Chen MF, Kim CH, Coleman AL, "Cyclodestructive procedures for refractory glaucoma". Cochrane Database Syst Rev, 2019, 3 (3), Cd012223.
4. Emanuel ME, Grover DS, Fellman RL et al., "Micropulse Cyclophotocoagulation: Initial Results in Refractory Glaucoma". J Glaucoma, 2017, 26 (8), 726-729.
5. Kuchar S, Moster MR, Reamer CB et al., "Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma". Lasers Med Sci, 2016, 31 (2), 393-6.
6. Li Z, Song Y, Chen X et al., "Biological Modulation of Mouse RPE Cells in Response to Subthreshold Diode Micropulse Laser Treatment". Cell Biochem Biophys, 2015, 73 (2), 545-552.
7. Pastor SA, Singh K, Lee DA et al., "Cyclophotocoagulation: a report by the American Academy of Ophthalmology". Ophthalmology, 2001, 108 (11), 2130-8.
8. Sanchez FG, Lerner F, Sampaolesi J et al., "Efficacy and Safety of Micropulse® Transscleral Cyclophotocoagulation in Glaucoma". Arch Soc Esp Oftalmol, Eficacia y seguridad de la ciclofotocoagulación transescleral con micropulsos en el tratamiento del glaucoma., 2018, 93 (12), 573-579.
9. Tham YC, Li X, Wong TY et al., "Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis". Ophthalmology, 2014, 121 (11), 2081-90.
10. Zaarour K, Abdelmassih Y, Arej N et al., "Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uncontrolled Glaucoma Patients". J Glaucoma, 2019, 28 (3), 270-275.